STAT

STAT+: Pharmalittle: Pfizer Covid pill retains 89% efficacy in full study; Senate committee holds hearing on FDA commissioner

The Pfizer pill to treat Covid-19 retained its 89% efficacy at preventing hospitalization and death in the full results of a study of high-risk patients.
Source: Alex Hogan/STAT

Rise and shine, folks, another busy day is on the way. We can tell, thanks to the cacophonous sounds of the street that are wafting

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Pharmalittle: We’re Watching A Ban Of Compounded Versions Of GLP-1s, A Biogen Acquisition, And More
Good morning from San Diego. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from the Pharmalittle campus. I’m not a coffee drinker, but who needs caffeine when you’ve got the raw adr
STAT1 min read
STAT+: Gene Therapies For Deafness Dredge Up An Old Question: Do Deaf People Want A ‘Cure’?
As scientists celebrate gene therapy's ability to enable hearing, deaf people are feeling a familiar dread: Are we endangered?
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanofi Licensing Novavax’s Covid Shot, Moderna’s RSV Vaccine, And More
Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.

Related Books & Audiobooks